Title: Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market [2010-2019] (1)
1Investigation Report on China Piperacillin Sodium
and Tazobactam Sodium Market 2010-2019
Market Reports On China
http//www.marketreportsonchina.com
2Summary
- Piperacillin sodium and tazobactam sodium is the
compound drug of piperacillin sodium and
tazobactam sodium, the former being
semi-synthesized broad-spectrum penicillin while
the latter being ß-lactamase inhibitor.
Tazobactam sodium can prevent piperacillin from
the ß-lactamase hydrolysis of some drug-resistant
bacteria so as to maintain piperacillins
antimicrobial activity or even expand its
spectrum. The injection product of Piperacillin
sodium and tazobactam sodium (piperacillin sodium
and tazobactam sodium for injection) is often
used in the clinic. - Since its first marketing in France in 1992,
piperacillin sodium and tazobactam sodium has
entered the US, mainland Europe, Japan and
Singapore. According to market survey,
piperacillin sodium and tazobactam sodium
develops fast after entering China in Oct. 1998,
annual sales value rising from less than CNY 2
million in 2005 to CNY 1.064 billion in 2014 and
CAGR during this period reaching 22.2.
Scope The report provides in-depth market
analysis, information and insights, including
? A detailed coverage of the travel and
tourism industry in China ? A comprehensive
analysis of the airlines market in China ?
Profile of the top airlines operating in China
3- Wyeth Pharmaceutical Co., Ltd (US), Qilu
Pharmaceutical Co., Ltd, North China
Pharmaceutical Group Corporation, Zhejiang
Anglikang Pharmaceutical Co., Ltd and United
Laboratories occupy the majority of the Chinese
market, among which Wyeth Pharmaceutical Co., Ltd
(US) has the largest market share of about 36
for sales value in 2014. - Piperacillin sodium and tazobactam sodium has
been widely applied in the clinic with efficacy
being confirmed by the randomized controlled
trials conducted by multiple centers at home and
abroad. And it has been recommended by many
domestic and foreign treatment guidelines as the
first choice of the initial empirical therapy for
hospital infection caused by unidentified
pathogenic bacteria. The market size of
piperacillin sodium and tazobactam sodium is
expected to grow in China or in the whole world. -
4 Readers can get at least the following
information from this report - market size of
piperacillin sodium and tazobactam sodium in
China - competitive landscape of piperacillin
sodium and tazobactam sodium in Chinese market -
price of piperacillin sodium and tazobactam
sodium made by different enterprises in China -
market outlook of piperacillin sodium and
tazobactam sodium in China
5- The author suggests the following groups of
people purchase this report - - manufacturers of anti-infectious drugs
- - investors/ research institutions interested in
Chinese medicine market - - any interest in the Chinese medicine market,
please contact CRI for customized survey service -
6Table Of Content
1 Related Concepts of Piperacillin Sodium
Tazobactam Sodium 2 Market Profile of
Piperacillin Sodium and Tazobactam Sodium in
China 3 Survey on Sales Status of Piperacillin
Sodium and Tazobactam Sodium in China,
2010-2014 4 Survey on Market Share of Major
Manufacturers of Piperacillin Sodium and
Tazobactam Sodium in China, 2010-2014 5 Survey
on Dosage Forms of Piperacillin Sodium and
Tazobactam Sodium in China, 2010-2014 6
Reference Price of Piperacillin Sodium and
Tazobactam Sodium in Chinese Hospitals in
2014
7To view the full Executive Summary and Table of
Contents, please visit Investigation Report
on China Piperacillin Sodium and Tazobactam
Sodium Market 2010-2019 Contact Us Market
Reports On ChinaContact No 91 2227810772,
27810773 Email id info_at_marketreportsonchina.co
m Website http//marketreportsonchina.com/